Zhong W - Search Results

1

Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer.

Liu J, Chen G, Liu Z, Liu S, Cai Z, You P, Ke Y, Lai L, Huang Y, Gao H, Zhao L, Pelicano H, Huang P, McKeehan WL, Wu CL, Wang C, Zhong W, Wang F. Liu J, et al. Among authors: zhong w. Cancer Res. 2018 Aug 15;78(16):4459-4470. doi: 10.1158/0008-5472.CAN-17-3226. Epub 2018 Jun 11. Cancer Res. 2018. PMID: 29891507 Free PMC article.

2

Expression of CD147 is associated with prostate cancer progression.

Zhong WD, Liang YX, Lin SX, Li L, He HC, Bi XC, Han ZD, Dai QS, Ye YK, Chen QB, Wang YS, Zeng GH, Zhu G, Zhang Z, Chen ZN, Wu CL. Zhong WD, et al. Int J Cancer. 2012 Jan 15;130(2):300-8. doi: 10.1002/ijc.25982. Epub 2011 Apr 27. Int J Cancer. 2012. PMID: 21328337 Free article.

3

Over-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomy.

Bi XC, Liu JM, Zheng XG, Xian ZY, Feng ZW, Lou YX, Zhong WD, Wu CL. Bi XC, et al. Clin Invest Med. 2011 Dec 1;34(6):E358. doi: 10.25011/cim.v34i6.15896. Clin Invest Med. 2011. PMID: 22129926

4

SOXs in human prostate cancer: implication as progression and prognosis factors.

Zhong WD, Qin GQ, Dai QS, Han ZD, Chen SM, Ling XH, Fu X, Cai C, Chen JH, Chen XB, Lin ZY, Deng YH, Wu SL, He HC, Wu CL. Zhong WD, et al. BMC Cancer. 2012 Jun 15;12:248. doi: 10.1186/1471-2407-12-248. BMC Cancer. 2012. PMID: 22703285 Free PMC article.

5

Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.

He HC, Ling XH, Zhu JG, Fu X, Han ZD, Liang YX, Deng YH, Lin ZY, Chen G, Chen YF, Mo RJ, Zhong WD. He HC, et al. Mol Biol Rep. 2013 May;40(5):3799-805. doi: 10.1007/s11033-012-2458-2. Epub 2013 Jan 3. Mol Biol Rep. 2013. PMID: 23283744

6

MicroRNA-335 acts as a candidate tumor suppressor in prostate cancer.

Xiong SW, Lin TX, Xu KW, Dong W, Ling XH, Jiang FN, Chen G, Zhong WD, Huang J. Xiong SW, et al. Among authors: zhong wd. Pathol Oncol Res. 2013 Jul;19(3):529-37. doi: 10.1007/s12253-013-9613-5. Epub 2013 Mar 3. Pathol Oncol Res. 2013. PMID: 23456549 Free article.

7

Expression of SOCSs in human prostate cancer and their association in prognosis.

Zhu JG, Dai QS, Han ZD, He HC, Mo RJ, Chen G, Chen YF, Wu YD, Yang SB, Jiang FN, Chen WH, Sun ZL, Zhong WD. Zhu JG, et al. Mol Cell Biochem. 2013 Sep;381(1-2):51-9. doi: 10.1007/s11010-013-1687-6. Epub 2013 May 11. Mol Cell Biochem. 2013. PMID: 23666742

8

A 32-gene risk index: a new prognostic approach for prostate cancer progression.

Cai C, Zhong WD, McDougal WS, Wu CL. Cai C, et al. Among authors: zhong wd. Asian J Androl. 2013 Sep;15(5):590-1. doi: 10.1038/aja.2013.85. Epub 2013 Jun 10. Asian J Androl. 2013. PMID: 23749003 Free PMC article. No abstract available.

9

MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.

Lin ZY, Huang YQ, Zhang YQ, Han ZD, He HC, Ling XH, Fu X, Dai QS, Cai C, Chen JH, Liang YX, Jiang FN, Zhong WD, Wang F, Wu CL. Lin ZY, et al. Int J Cancer. 2014 Aug 1;135(3):541-50. doi: 10.1002/ijc.28707. Epub 2014 Jan 10. Int J Cancer. 2014. PMID: 24382668 Free article.

10

Elevated levels of mitochondrion-associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer.

Jiang X, Li X, Huang H, Jiang F, Lin Z, He H, Chen Y, Yue F, Zou J, He Y, You P, Wang W, Yang W, Zhao H, Lai Y, Wang F, Zhong W, Liu L. Jiang X, et al. Among authors: zhong w. Cancer. 2014 Apr 15;120(8):1228-36. doi: 10.1002/cncr.28551. Epub 2014 Jan 3. Cancer. 2014. PMID: 24390809 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,417 results

Search Page